Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Interpreting the results of Parkinson's disease clinical trials: Time for a change

Identifieur interne : 000281 ( Main/Exploration ); précédent : 000280; suivant : 000282

Interpreting the results of Parkinson's disease clinical trials: Time for a change

Auteurs : Nick H. G. Holford [Nouvelle-Zélande] ; John G. Nutt [États-Unis]

Source :

RBID : ISTEX:0A98FC6965B2BF028342E3D6620F870F0E9008A3

English descriptors

Abstract

Randomized clinical trials testing putative disease‐modifying agents in Parkinson's disease (PD) have yielded controversial results that have not influenced evidence‐based recommendations for the treatment of PD. We argue that the failure of these clinical trials may be linked to end point‐based statistical analyses that must make prior assumptions about the magnitude and the time course of wash‐in and wash‐out of drug effects. Many of these shortcomings may be avoided with quantitative modeling of the entire time course of the clinical trial and examining evidence for three concomitant processes, disease progression, symptomatic drug effects and disease modifying effects. The power of this approach is illustrated by modeling of DATATOP and ELLDOPA trial data. © 2010 Movement Disorder Society

Url:
DOI: 10.1002/mds.23555


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Interpreting the results of Parkinson's disease clinical trials: Time for a change</title>
<author>
<name sortKey="Holford, Nick H G" sort="Holford, Nick H G" uniqKey="Holford N" first="Nick H. G." last="Holford">Nick H. G. Holford</name>
</author>
<author>
<name sortKey="Nutt, John G" sort="Nutt, John G" uniqKey="Nutt J" first="John G." last="Nutt">John G. Nutt</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0A98FC6965B2BF028342E3D6620F870F0E9008A3</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1002/mds.23555</idno>
<idno type="url">https://api.istex.fr/document/0A98FC6965B2BF028342E3D6620F870F0E9008A3/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">000718</idno>
<idno type="wicri:Area/Main/Curation">000627</idno>
<idno type="wicri:Area/Main/Exploration">000281</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Interpreting the results of Parkinson's disease clinical trials: Time for a change</title>
<author>
<name sortKey="Holford, Nick H G" sort="Holford, Nick H G" uniqKey="Holford N" first="Nick H. G." last="Holford">Nick H. G. Holford</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Nouvelle-Zélande</country>
<wicri:regionArea>University of Auckland, Auckland</wicri:regionArea>
<wicri:noRegion>Auckland</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Nutt, John G" sort="Nutt, John G" uniqKey="Nutt J" first="John G." last="Nutt">John G. Nutt</name>
<affiliation wicri:level="4">
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Oregon Health & Science University, Portland, Oregon</wicri:regionArea>
<placeName>
<region type="state">Oregon</region>
<settlement type="city">Portland</settlement>
</placeName>
<orgName type="university">Université des sciences et de la médecine de l'Oregon</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2011-03">2011-03</date>
<biblScope unit="volume">26</biblScope>
<biblScope unit="issue">4</biblScope>
<biblScope unit="page" from="569">569</biblScope>
<biblScope unit="page" to="577">577</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">0A98FC6965B2BF028342E3D6620F870F0E9008A3</idno>
<idno type="DOI">10.1002/mds.23555</idno>
<idno type="ArticleID">MDS23555</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Parkinson's disease</term>
<term>clinical trials</term>
<term>disease‐modifying therapies</term>
<term>modeling clinical trials</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Randomized clinical trials testing putative disease‐modifying agents in Parkinson's disease (PD) have yielded controversial results that have not influenced evidence‐based recommendations for the treatment of PD. We argue that the failure of these clinical trials may be linked to end point‐based statistical analyses that must make prior assumptions about the magnitude and the time course of wash‐in and wash‐out of drug effects. Many of these shortcomings may be avoided with quantitative modeling of the entire time course of the clinical trial and examining evidence for three concomitant processes, disease progression, symptomatic drug effects and disease modifying effects. The power of this approach is illustrated by modeling of DATATOP and ELLDOPA trial data. © 2010 Movement Disorder Society</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Nouvelle-Zélande</li>
<li>États-Unis</li>
</country>
<region>
<li>Oregon</li>
</region>
<settlement>
<li>Portland</li>
</settlement>
<orgName>
<li>Université des sciences et de la médecine de l'Oregon</li>
</orgName>
</list>
<tree>
<country name="Nouvelle-Zélande">
<noRegion>
<name sortKey="Holford, Nick H G" sort="Holford, Nick H G" uniqKey="Holford N" first="Nick H. G." last="Holford">Nick H. G. Holford</name>
</noRegion>
</country>
<country name="États-Unis">
<region name="Oregon">
<name sortKey="Nutt, John G" sort="Nutt, John G" uniqKey="Nutt J" first="John G." last="Nutt">John G. Nutt</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000281 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000281 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:0A98FC6965B2BF028342E3D6620F870F0E9008A3
   |texte=   Interpreting the results of Parkinson's disease clinical trials: Time for a change
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024